Omega 3 on fatty liver
Not Applicable
- Conditions
- Fatty (change of) liver.Nonalcoholic fatty liver disease (NAFLD)
- Registration Number
- IRCT2013052313427N1
- Lead Sponsor
- Fasa University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
The patient who diagnosed as fatty liver disease by increase in ALT and AST and liver ultrasonography with 4 criteria of sonography added to intervention.The patient who hasn't sign the permission form, or drink ethanol more than 20 gram in a day or take some drugs that cause of fatty liver such as steroids,sterogen,amiodaron,tamoxifen in 6 month ago and patient who has Hepatit B and C,auto immune hepatitis, wilson, hemachromatosis, decrease of alpha-1-antitripsin or sever disease such as heart, liver, psychology disease was eliminated.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatty liver. Timepoint: Before intervention, 3 months after intervention. Method of measurement: AST, ALT(liver enzymes).
- Secondary Outcome Measures
Name Time Method